Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001851722 | SCV002177079 | pathogenic | not provided | 2021-11-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects PRKN function (PMID: 25591737). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 7051). This missense change has been observed in individual(s) with early-onset Parkinson disease (PMID: 11222808, 15970950, 25833766). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs137853060, gnomAD 0.004%). This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 211 of the PRKN protein (p.Lys211Asn). |
Human Genetics Bochum, |
RCV000007467 | SCV004704497 | likely pathogenic | Autosomal recessive juvenile Parkinson disease 2 | 2023-05-09 | criteria provided, single submitter | clinical testing | ACMG criteria used to clasify this variant: PM1, PP3_MOD, PS3_SUP, PP2 |
Mayo Clinic Laboratories, |
RCV001851722 | SCV005413767 | pathogenic | not provided | 2023-10-09 | criteria provided, single submitter | clinical testing | PM2_moderate, PM3_strong, PS3_moderate, PS4_moderate |
OMIM | RCV000007467 | SCV000027667 | pathogenic | Autosomal recessive juvenile Parkinson disease 2 | 2005-09-01 | no assertion criteria provided | literature only | |
Solve- |
RCV004766986 | SCV005091299 | likely pathogenic | Ovarian cancer | 2022-06-01 | no assertion criteria provided | provider interpretation | Variant confirmed as disease-causing by referring clinical team |